Monarch Launches to Empower Women's Health Physicians with a Bold New Model for Independent, Membership-Based Care
Built by physicians and industry veterans, Monarch helps physicians reclaim autonomy, reduce burnout, and deliver relationship-driven care
NEW YORK, June 10, 2025--(BUSINESS WIRE)--Monarch has officially launched to transform the future of women's healthcare by enabling physicians to establish and operate independent, membership-based practices. Founded by physicians and industry veterans, Monarch's approach supports a sustainable alternative to traditional systems that limit time, access, and quality of care, ensuring doctors retain complete ownership, clinical decision-making authority, and professional autonomy.
Addressing Crisis-Level Burnout and Patient Dissatisfaction
After assembling its first physician cohort, Monarch launches amid growing urgency and demand for a better way to practice medicine. Recent reports show that nearly half of U.S. physicians report experiencing symptoms of burnout, which particularly impacts women's healthcare where complex care requires longer consultations that current reimbursement models fail to adequately support. Women across the country also face increasing delays, dismissals, misdiagnosis, and fragmented care. These disparities underscore the need for a better healthcare model.
Monarch helps remove the friction and bureaucracy that drives burnout and prevents physicians from delivering the care their patients deserve. By providing comprehensive operational infrastructure, dedicated launch support, and robust practice management tools, Monarch enables physicians to spend significantly more time delivering thoughtful, preventive care that reflects the full complexity of women's health rather than being overwhelmed by administrative burdens.
"Monarch was built to address a fundamental failure in healthcare: The system is broken, and it's women who are too often overlooked, underserved, and left behind," said Anna Lohrfink, Co-Founder and Chief Product Officer of Monarch. "Our mission is simple: Empower great doctors to deliver the care women deserve—personal, proactive, and focused on helping them thrive in every stage of life."
Built for Physician Independence and Patient-Centered Care
Monarch-affiliated physicians retain full ownership of their practices and complete clinical decision-making power. Monarch minimizes administrative burden—from staffing to billing, marketing, and technology integration—enabling physicians to maintain smaller patient panels, offer extended appointments, provide greater care continuity, and generate more predictable revenue through the membership model.
"Monarch makes it possible to practice medicine the way it was always meant to be practiced—rooted in deep relationships, centered on the full spectrum of health, and driven by clinical excellence," said Dr. Suzanne Gilberg, Chief Clinical Officer, Monarch. "We're not opting out of the healthcare system—we're building what it should have been all along, for both patients and physicians."
Proven Leadership and Vision
Monarch's founding team combines deep expertise in healthcare delivery, digital health, and practice operations, supported by distinguished clinical advisors specializing in women's health, concierge medicine, and healthcare innovation. This helps ensure the platform remains grounded in the real needs of both patients and providers.
"This is about giving physicians their professional identity back," added Lohrfink. "When doctors are free to build meaningful relationships with patients—without the noise of administrative red tape—healthcare finally does what it's meant to do: help people live healthier, fuller lives."
About Monarch
Monarch is the premier partner for women's health physicians who want to leave behind a high-volume, insurance-driven care and build independent practices that deliver exceptional, personalized care for women at every stage of life. Monarch provides the operational support, technology, and investment physicians need—without taking away ownership or clinical autonomy. With Monarch's proven model, physicians reduce patient volume, deliver proactive, personalized care, and build stronger relationships with their patients.
Physicians interested in learning more about Monarch can visit www.monarchmd.com and follow Monarch on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250610956890/en/
Contacts
Giana Gaughangiana.gaughan@monarchmd.com 708-703-2210

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Destiny Tech100 Inc. Reports First Quarter 2025 Results
NEW YORK, June 13, 2025--(BUSINESS WIRE)--Destiny Tech100 Inc. (NYSE: DXYZ) today announced financial results for the quarter ended March 31, 2025. The fund reported a net asset value (NAV) of $6.31 per share of common stock, from $6.44 per share at the end of the fourth quarter of 2024. As of March 31, 2025, Destiny Tech100's investment portfolio had an aggregate fair value of approximately $69.6 million, including short-term investments. The fund maintains positions in a variety of privately-held technology companies. Additional Information For more information about the Tech100 fund, Destiny XYZ Inc., the Fund's parent company, has made extensive resources available on its website. Prospective investors and the general public are encouraged to visit (in the Literature section) to receive the Fund's most recent annual report and other important information. About Destiny Tech100 Destiny Tech100 ("DXYZ" and "Tech100"), is a publicly-listed registered closed-end fund that intends to invest in a portfolio of 100 of the top venture-backed private technology companies, providing everyday investors access to many of the world's most exciting private businesses. Destiny Tech100 Inc. is currently listed on the New York Stock Exchange under the ticker symbol "DXYZ." For a comprehensive list of holdings, visit the fund website at View source version on Contacts Robert Blecherpress@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Destiny Tech100 Inc. Reports First Quarter 2025 Results
NEW YORK, June 13, 2025--(BUSINESS WIRE)--Destiny Tech100 Inc. (NYSE: DXYZ) today announced financial results for the quarter ended March 31, 2025. The fund reported a net asset value (NAV) of $6.31 per share of common stock, from $6.44 per share at the end of the fourth quarter of 2024. As of March 31, 2025, Destiny Tech100's investment portfolio had an aggregate fair value of approximately $69.6 million, including short-term investments. The fund maintains positions in a variety of privately-held technology companies. Additional Information For more information about the Tech100 fund, Destiny XYZ Inc., the Fund's parent company, has made extensive resources available on its website. Prospective investors and the general public are encouraged to visit (in the Literature section) to receive the Fund's most recent annual report and other important information. About Destiny Tech100 Destiny Tech100 ("DXYZ" and "Tech100"), is a publicly-listed registered closed-end fund that intends to invest in a portfolio of 100 of the top venture-backed private technology companies, providing everyday investors access to many of the world's most exciting private businesses. Destiny Tech100 Inc. is currently listed on the New York Stock Exchange under the ticker symbol "DXYZ." For a comprehensive list of holdings, visit the fund website at View source version on Contacts Robert Blecherpress@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Business Wire
2 hours ago
- Business Wire
Federal Court in Delaware Dismisses Antitrust Challenge to Wabtec-GE Transportation Merger
PITTSBURGH--(BUSINESS WIRE)--The United States District Court for the District of Delaware has dismissed all antitrust claims filed in a lawsuit challenging the merger between Wabtec (NYSE: WAB) and GE Transportation. The Court said no harmful effects on competition resulting from the merger had been shown and also dismissed remaining antitrust allegations. The Court did not grant Wabtec's motion to dismiss alleged breach of contract and other claims, which Wabtec intends to vigorously defend. Kyra Yates, Vice President of Investor Relations for Wabtec said: "We are pleased with the Court's ruling, which affirms the value and integrity of the Wabtec-GE Transportation merger for the industry and all its stakeholders." About Wabtec Wabtec Corporation (NYSE: WAB) is focused on creating transportation solutions that move and improve the world. The company is a leading global provider of equipment, systems, digital solutions and value-added services for the freight and transit rail industries, as well as the mining, marine and industrial markets. Wabtec has been a leader in the rail industry for over 155 years and has a vision to achieve a sustainable rail system in the U.S. and worldwide. Visit Wabtec's website at: